文献速递生殖医学母胎医学

白细胞介素-34存在于母胎界面,并在体外诱导具有蜕膜表型的免疫调节性巨噬细胞

Interleukin-34 is present at the fetal-maternal interface and induces immunoregulatory macrophages of a decidual phenotype in vitro.
PubMed 文献 · Hum Reprod · 2018-01-01

本研究采用免疫组化和ELISA检测早孕期母胎界面组织(n=49)及子痫前期与对照晚期胎盘(n=21与n=15)中白细胞介素-34(IL-34)的表达,并在健康志愿者外周血单核细胞体外模型(n=14)中评估其对巨噬细胞极化的影响。结果显示IL-34由胎盘细胞滋养细胞、合体滋养细胞和蜕膜基质细胞产生,体外可使单核细胞极化为CD14highCD163+CD209+、细胞因子分泌模式类似蜕膜巨噬细胞的表型,该表型与M-CSF诱导者相似但不完全相同,且与GM-CSF诱导的M1样巨噬细胞显著不同(P<0.05-0.0001,因标志物而异)。

要点

  • IL-34存在于母胎界面,由胎盘细胞滋养细胞、合体滋养细胞及蜕膜基质细胞产生。
  • IL-34体外诱导的单核细胞来源巨噬细胞表型为CD14highCD163+CD209+,分泌模式类似蜕膜巨噬细胞。
  • IL-34诱导表型与M-CSF诱导者相似但不完全相同,与GM-CSF诱导的M1样巨噬细胞显著不同。

核心结论

  • IL-34存在于母胎界面,并在体外使单核细胞极化为具有蜕膜表型的免疫调节性巨噬细胞。
  • 作者认为IL-34可能通过使巨噬细胞极化为调节性表型,参与母胎界面耐受环境的建立。

研究设计与样本

  • 采用免疫组化和ELISA检测早孕期(选自择期手术终止妊娠,n=49)胎盘与蜕膜组织及分离的滋养细胞和蜕膜基质细胞中IL-34的存在。
  • 同时评估晚期胎盘活检中IL-34表达,对象为子痫前期孕妇(n=21)与无子痫前期孕妇(n=15)。
  • 在健康志愿者(n=14)外周血单核细胞体外模型中评估IL-34对巨噬细胞极化的影响,以GM-CSF作为M1样极化生长因子、M-CSF作为M2样极化生长因子。
  • 体外巨噬细胞极化通过流式细胞表型分析和无细胞上清多重微珠法检测细胞因子与趋化因子分泌来判定。

主要发现

  • IL-34由胎盘细胞滋养细胞、合体滋养细胞和蜕膜基质细胞产生。
  • IL-34在体外使外周血单核细胞极化为CD14highCD163+CD209+、细胞因子分泌模式类似蜕膜巨噬细胞的巨噬细胞。
  • IL-34诱导的表型与M-CSF诱导的表型相似但不完全相同;IL-34诱导和M-CSF诱导的巨噬细胞均与GM-CSF极化的M1样巨噬细胞显著不同(P<0.05-0.0001,因标志物而异)。

临床怎么用

  • 作者认为,关于巨噬细胞极化的生长因子知识可能有望转化用于治疗涉及该过程失调的妊娠并发症。

局限性

  • 原文指出,尽管IL-34存在于母胎界面并在体外使巨噬细胞极化,但其在体内的确切作用仍有待确定。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: Is the newly discovered cytokine interleukin (IL)-34 expressed at the human fetal-maternal interface in order to influence polarization of monocytes into macrophages of a decidual immunoregulatory phenotype? SUMMARY ANSWER: IL-34 was found to be present at the fetal-maternal interface, in both fetal placenta and maternal decidua, and it was able to polarize monocytes into macrophages of a decidual phenotype. WHAT IS KNOWN ALREADY: IL-34 was shown to bind to the same receptor as macrophage-colony stimulating factor (M-CSF), which has an important immunomodulatory role at the fetal-maternal interface, for example by polarizing decidual macrophages to an M2-like regulatory phenotype. IL-34 is known to regulate macrophage subsets, such as microglia and Langerhans cells, but its presence at the fetal-maternal interface is unknown. STUDY DESIGN, SIZE, DURATION: The presence of IL-34 at the fetal-maternal interface was evaluated by immunohistochemistry (IHC) and ELISA in placental and decidual tissues as well as in isolated trophoblast cells and decidual stromal cells obtained from first trimester elective surgical terminations of pregnancy (n = 49). IL-34 expression was also assessed in third trimester placental biopsies from women with (n = 21) or without (n = 15) pre-eclampsia. The effect of IL-34 on macrophage polarization was evaluated in an in vitro model of blood monocytes obtained from healthy volunteers (n = 14). In this model, granulocyte macrophage-colony stimulating factor (GM-CSF) serves as a growth factor for M1-like polarization, and M-CSF as a growth factor for M2-like polarization. PARTICIPANTS/MATERIALS, SETTING, METHODS: First trimester placental and decidual tissues were obtained from elective pregnancy terminations. Placental biopsies were obtained from women with pre-eclampsia and matched controls in the delivery ward. Polarization of macrophages in vitro was determined by flow-cytometric phenotyping and secretion of cytokines and chemokines in cell-free supernatants by multiplex bead assay. MAIN RESULTS AND THE ROLE OF CHANCE: Our study shows that IL-34 is produced at the fetal-maternal interface by both placental cyto- and syncytiotrophoblasts and decidual stromal cells. We also show that IL-34, in vitro, is able to polarize blood monocytes into macrophages with a phenotype (CD14highCD163+CD209+) and cytokine secretion pattern similar to that of decidual macrophages. The IL-34-induced phenotype was similar, but not identical to the phenotype induced by M-CSF, and both IL-34- and M-CSF-induced macrophages were significantly different (P < 0.05-0.0001 depending on marker) from GM-CSF-polarized M1-like macrophages. Our findings suggest that IL-34 is involved in the establishment of the tolerant milieu found at the fetal-maternal interface by skewing polarization of macrophages into a regulatory phenotype. LIMITATIONS, REASONS FOR CAUTION: Although it is clear that IL-34 is present at the fetal-maternal interface and polarizes macrophages in vitro, its precise role in vivo remains to be established. WIDER IMPLICATIONS OF THE FINDINGS: The recently discovered cytokine IL-34 is present at the fetal-maternal interface and has immunomodulatory properties with regard to induction of decidual macrophages, which are important for a healthy pregnancy. Knowledge of growth factors related to macrophage polarization can potentially be translated to treatment of pregnancy complications involving dysregulation of this process. STUDY FUNDING/COMPETING INTEREST(S): This study was funded by grants from the Medical Research Council (Grant K2013-61X-22310-01-04), the Research Council of South-East Sweden (FORSS), and the County Council of Östergötland, Sweden. No author has any conflicts of interest to declare.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Lindau R, Mehta RB, Lash GE, et al. Interleukin-34 is present at the fetal-maternal interface and induces immunoregulatory macrophages of a decidual phenotype in vitro. Hum Reprod. 2018. PMID: 29579271. doi:10.1093/humrep/dey037

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。